Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.

To assess the role of the kynurenine pathway in the pathology of Alzheimer's disease (AD), the expression and localization of key components of the kynurenine pathway including the key regulatory enzyme tryptophan 2,3 dioxygenase (TDO), and the metabolites tryptophan, kynurenine, kynurenic acid...

Full description

Bibliographic Details
Main Authors: Wei Wu, Joseph A Nicolazzo, Li Wen, Roger Chung, Roger Stankovic, Shisan S Bao, Chai K Lim, Bruce J Brew, Karen M Cullen, Gilles J Guillemin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23630570/?tool=EBI
_version_ 1818389013629763584
author Wei Wu
Joseph A Nicolazzo
Li Wen
Roger Chung
Roger Stankovic
Shisan S Bao
Chai K Lim
Bruce J Brew
Karen M Cullen
Gilles J Guillemin
author_facet Wei Wu
Joseph A Nicolazzo
Li Wen
Roger Chung
Roger Stankovic
Shisan S Bao
Chai K Lim
Bruce J Brew
Karen M Cullen
Gilles J Guillemin
author_sort Wei Wu
collection DOAJ
description To assess the role of the kynurenine pathway in the pathology of Alzheimer's disease (AD), the expression and localization of key components of the kynurenine pathway including the key regulatory enzyme tryptophan 2,3 dioxygenase (TDO), and the metabolites tryptophan, kynurenine, kynurenic acid, quinolinic acid and picolinic acid were assessed in different brain regions of triple transgenic AD mice. The expression and cell distribution of TDO and quinolinic acid, and their co-localization with neurofibrillary tangles and senile β amyloid deposition were also determined in hippocampal sections from human AD brains. The expression of TDO mRNA was significantly increased in the cerebellum of AD mouse brain. Immunohistochemistry demonstrated that the density of TDO immuno-positive cells was significantly higher in the AD mice. The production of the excitotoxin quinolinic acid strongly increased in the hippocampus in a progressive and age-dependent manner in AD mice. Significantly higher TDO and indoleamine 2,3 dioxygenase 1 immunoreactivity was observed in the hippocampus of AD patients. Furthermore, TDO co-localizes with quinolinic acid, neurofibrillary tangles-tau and amyloid deposits in the hippocampus of AD. These results show that the kynurenine pathway is over-activated in AD mice. This is the first report demonstrating that TDO is highly expressed in the brains of AD mice and in AD patients, suggesting that TDO-mediated activation of the kynurenine pathway could be involved in neurofibrillary tangles formation and associated with senile plaque. Our study adds to the evidence that the kynurenine pathway may play important roles in the neurodegenerative processes of AD.
first_indexed 2024-12-14T04:34:59Z
format Article
id doaj.art-c69cbd3ce9a345eab273769269126948
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T04:34:59Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c69cbd3ce9a345eab2737692691269482022-12-21T23:16:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0184e5974910.1371/journal.pone.0059749Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.Wei WuJoseph A NicolazzoLi WenRoger ChungRoger StankovicShisan S BaoChai K LimBruce J BrewKaren M CullenGilles J GuilleminTo assess the role of the kynurenine pathway in the pathology of Alzheimer's disease (AD), the expression and localization of key components of the kynurenine pathway including the key regulatory enzyme tryptophan 2,3 dioxygenase (TDO), and the metabolites tryptophan, kynurenine, kynurenic acid, quinolinic acid and picolinic acid were assessed in different brain regions of triple transgenic AD mice. The expression and cell distribution of TDO and quinolinic acid, and their co-localization with neurofibrillary tangles and senile β amyloid deposition were also determined in hippocampal sections from human AD brains. The expression of TDO mRNA was significantly increased in the cerebellum of AD mouse brain. Immunohistochemistry demonstrated that the density of TDO immuno-positive cells was significantly higher in the AD mice. The production of the excitotoxin quinolinic acid strongly increased in the hippocampus in a progressive and age-dependent manner in AD mice. Significantly higher TDO and indoleamine 2,3 dioxygenase 1 immunoreactivity was observed in the hippocampus of AD patients. Furthermore, TDO co-localizes with quinolinic acid, neurofibrillary tangles-tau and amyloid deposits in the hippocampus of AD. These results show that the kynurenine pathway is over-activated in AD mice. This is the first report demonstrating that TDO is highly expressed in the brains of AD mice and in AD patients, suggesting that TDO-mediated activation of the kynurenine pathway could be involved in neurofibrillary tangles formation and associated with senile plaque. Our study adds to the evidence that the kynurenine pathway may play important roles in the neurodegenerative processes of AD.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23630570/?tool=EBI
spellingShingle Wei Wu
Joseph A Nicolazzo
Li Wen
Roger Chung
Roger Stankovic
Shisan S Bao
Chai K Lim
Bruce J Brew
Karen M Cullen
Gilles J Guillemin
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
PLoS ONE
title Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
title_full Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
title_fullStr Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
title_full_unstemmed Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
title_short Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain.
title_sort expression of tryptophan 2 3 dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human alzheimer s disease brain
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23630570/?tool=EBI
work_keys_str_mv AT weiwu expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT josephanicolazzo expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT liwen expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT rogerchung expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT rogerstankovic expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT shisansbao expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT chaiklim expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT brucejbrew expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT karenmcullen expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain
AT gillesjguillemin expressionoftryptophan23dioxygenaseandproductionofkynureninepathwaymetabolitesintripletransgenicmiceandhumanalzheimersdiseasebrain